Growth Metrics

Eli Lilly (LLY) Retained Earnings (2016 - 2025)

Eli Lilly's Retained Earnings history spans 17 years, with the latest figure at $24.5 billion for Q4 2025.

  • For Q4 2025, Retained Earnings rose 666.17% year-over-year to $24.5 billion; the TTM value through Dec 2025 reached $24.5 billion, up 666.17%, while the annual FY2025 figure was $24.5 billion, 666.17% up from the prior year.
  • Retained Earnings reached $24.5 billion in Q4 2025 per LLY's latest filing, up from $22.3 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $24.5 billion in Q4 2025 to a low of -$6.4 billion in Q1 2021.
  • Average Retained Earnings over 5 years is $3.1 billion, with a median of -$4.0 billion recorded in 2022.
  • Peak YoY movement for Retained Earnings: crashed 208.78% in 2021, then skyrocketed 666.17% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$4.3 billion in 2021, then surged by 331.23% to $10.0 billion in 2022, then grew by 2.69% to $10.3 billion in 2023, then crashed by 141.91% to -$4.3 billion in 2024, then surged by 666.17% to $24.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Retained Earnings are $24.5 billion (Q4 2025), $22.3 billion (Q3 2025), and $17.4 billion (Q2 2025).